Key Takeaways
- • Carlyle Group reported third-quarter distributable earnings of $1.12 per share for the three months to September, ahead of analyst expectations of $1.00, according to Reuters.
- • Realised net performance revenue rose to $99.8m from $19.1m a year earlier, reflecting a recovery in investment monetisations after a prolonged slowdown in private equity exits.
- • Carlyle completed the sale of Tescan Group and sold a 27% stake in Rigaku during the quarter, and has signed nearly $6bn of additional exits expected to close in the fourth quarter.
- • Capital inflows totalled $10.8bn in the quarter, led by credit strategies, against $11bn of deployment; the firm expects at least $20bn of inflows in Q4, supported by a reinsurance transaction with Unum Group.
- • Fee-related earnings fell 6% to $293m, signalling continued pressure on recurring profitability.
Summary
Realised net performance revenue increased to $99.8m from $19.1m a year earlier. The company attributed the increase to a recovery in investment monetisations following a prolonged slowdown in private equity exit activity across the industry.
During the quarter, Carlyle completed the sale of electron microscope manufacturer Tescan Group and sold a 27% stake in Japanese testing equipment maker Rigaku. The firm has also reportedly signed nearly $6bn of additional exits expected to complete in the fourth quarter. Chief executive Harvey Schwartz said Carlyle had returned almost $100bn to investors since the beginning of 2024.
Capital inflows totalled $10.8bn in the quarter, driven primarily by credit strategies, while deployment reached $11bn. Carlyle expects at least $20bn of inflows in the fourth quarter, supported by a reinsurance transaction with Unum Group.
The results were not uniformly positive. Fee-related earnings declined 6% to $293m, highlighting continued pressure on the firm's recurring profitability even as realisation activity improved.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.